Changeflow GovPing Pharma & Drug Safety Medline Recalls Namic Angiographic Syringes Ove...
Urgent Enforcement Amended Final

Medline Recalls Namic Angiographic Syringes Over Unwinding Risk

Favicon for www.fda.gov FDA Medical Device Recalls
Filed
Detected
Email

Summary

Medline Industries issued an urgent medical device recall for Namic Angiographic Rotating Adaptor (RA) Control Syringes and Convenience Kits after identifying that the syringe rotating adaptor may unwind during use, causing loose connections or full disconnection from the manifold. The FDA has classified this as the most serious recall type due to the risk of biohazard exposure, blood loss, infection, air embolism, serious injury, or death. Four serious injuries have been reported as of March 13.

What changed

Medline Industries, in coordination with the FDA, initiated a Class I recall of Namic Angiographic Rotating Adaptor (RA) Control Syringes and Convenience Kits containing RA Syringes. The recall was triggered by reports that the syringe rotating adaptor may unwind during use, resulting in loose connections or full disconnection between the syringe and manifold. The failure creates risks of biohazard exposure, blood loss, infection, air embolism, and death. All units are affected and four serious injuries have been reported. The recall notice was issued February 27 to affected customers with immediate quarantine and destruction instructions.

Healthcare facilities, distributors, and any entity using or reselling these syringes must immediately check stock for affected products, quarantine inventory, and destroy affected items after completing recall response forms. Over-labels must be applied to affected kits. In rare emergency situations where no alternative exists and postponement poses significant patient risk, the syringe may be used only with manual stabilization, continuous 100% monitoring, and strict adherence to usage guidelines.

What to do next

  1. Quarantine and destroy all affected Namic RA Syringes per recall response forms
  2. Apply over-labels to affected kits on hand stating affected syringes must be removed and discarded
  3. Notify downstream distributors or resellers of this recall communication

Archived snapshot

Apr 10, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.


This recall **involves removing devices from where they are used or sold.* The FDA has identified this recall as the most serious type. This device may cause serious injury or death if you continue to use it.*

Affected Product

The FDA is aware that Medline Industries has issued an Urgent Medical Device Recall to affected customers recommending all Namic Angiographic Rotating Adaptor (RA) Control Syringes and Convenience Kits containing RA Syringes be removed from where they are used or sold. Affected devices:

  • Namic Angiographic Rotating Adaptor (RA) Control Syringes
  • Convenience Kits containing Namic Angiographic Rotating Adaptor (RA) Control Syringes Full list of affected products.

What to Do

Remove and destroy all Namic RA Syringes. Apply over-labels to all affected kits on hand stating that the affected syringes must be removed and discarded from further use.

On February 27, Medline Industries sent all affected customers an Urgent Medical Device Recall notice recommending the following actions:

  • Immediately check your stock for any affected product and quarantine. Destroy affected product after completing recall response forms.
  • Apply provided over-labels to any affected kits on hand stating that the affected syringes must be removed and discarded from further use.
  • If you are a distributor or have resold or transferred this product, notify them of this recall communication.
  • In rare circumstances where angiography is urgently required, no alternative device is available, and postponing the procedure would place the patient at significant risk, the Namic RA syringe may be used with extreme caution and vigilance.
    • Precautions include manual stabilization of syringe-to-manifold connections and continuous, 100% monitoring during setup and throughout the entire procedure.  Strict adherence to all usage guidelines and the Instructions for Use is also required.
    • If use is unavoidable, be prepared to follow the additional instructions provided in the Urgent Medical Device Recall notice if the syringe unwinds and causes a loose connection or disconnection during procedural setup or during the procedure.

Reason for Recall

Medline Industries stated that the syringe rotating adaptor on affected devices may unwind during use, resulting in a loose connection or full disconnection between the syringe and manifold. If unwinding occurs, there is potential for biohazard exposure, blood loss, and infection. Loose connections or disconnections may introduce air into the line, which could result in air embolism. These conditions may lead to serious injury or death. All units have the potential to exhibit this failure mode.

As of March 13, Medline Industries has reported four serious injuries and no deaths associated with this issue.

Device Use

The Namic Angiographic Control Syringe is intended to be used for the intra-arterial or intravenous administration of radiographic contrast media.

Contact Information

Customers in the U.S. with adverse reactions, quality problems, or questions about this issue should contact Medline Industries at recalls@medline.com or 866-359-1704.

Additional FDA Resources

  1. FDA Enforcement Report
  2. CDRH Medical Device Recall Database

Unique Device Identifier (UDI)

The unique device identifier (UDI) helps identify individual medical devices sold in the United States from distribution to use. The UDI allows for more accurate reporting, reviewing, and analyzing of adverse event reports so that devices can be identified more quickly, and as a result, problems potentially resolved more quickly.

How do I report a problem?

Health care professionals and consumers may report adverse reactions or quality problems they experienced using these devices to MedWatch: The FDA Safety Information and Adverse Event Reporting Program.

  • ## Content current as of:

04/09/2026

  • Regulated Product(s)

    • Medical Devices

Named provisions

Namic Angiographic RA Control Syringe Recall Namic Angiographic RA Convenience Kit Recall

Get daily alerts for FDA Medical Device Recalls

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from FDA.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
FDA
Filed
February 27th, 2025
Compliance deadline
February 27th, 2025 (413 days ago)
Instrument
Enforcement
Legal weight
Binding
Stage
Final
Change scope
Substantive
Document ID
FDA Enforcement Report, Recall No. 98598

Who this affects

Applies to
Healthcare providers Medical device makers Distributors
Industry sector
3345 Medical Device Manufacturing
Activity scope
Medical device recall Angiography procedures Contrast media administration
Geographic scope
United States US

Taxonomy

Primary area
Medical Devices
Operational domain
Clinical Operations
Compliance frameworks
GxP
Topics
Product Safety Public Health

Get alerts for this source

We'll email you when FDA Medical Device Recalls publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!